DuPont de NemoursDD
Recorded

DuPont de Nemours 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration56 minParticipants19

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Thank you for standing by, and welcome to the DuPont third quarter 2026 financial results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during that time, simply press star, then the number one on your telephone keypad. I would now like to turn the call over to Ann Giancristoforo, Vice President of Investor Relations.

Ann GiancristoforoVP of Investor Relations

Please go ahead. Good morning, and thank you for joining us for DuPont's third quarter 2026 financial results conference call.

Ann GiancristoforoVP of Investor Relations

Joining me today are Lori Koch, Chief Executive Officer, and Antonella Franzen, Chief Financial Officer. We have prepared slides to supplement our remarks, which are posted on DuPont's website under the Investor Relations tab and through the webcast link. Please read the forward-looking statement disclaimer contained in the slides. During this call, we will make forward-looking statements regarding our expectations or predictions about the future. Because these statements are based on current assumptions and factors that involve risks and uncertainties, our actual performance and results may differ materially from our forward-looking statements. Our Form 10-K, as updated by our current and periodic reports, includes detailed discussion of principal risks and uncertainties which may cause such differences.

Ann GiancristoforoVP of Investor Relations

Unless otherwise specified, all historical financial measures presented today are on a continuing operations basis and exclude significant items. We will also refer to other non-GAAP measures. A reconciliation to the most directly comparable GAAP financial measure is included in our press release and presentation materials and has been posted to DuPont's Investor Relations website. Consistent with our prior earnings calls, we will provide comments on our results versus the prior year pro forma, which adjusts for our post-separation corporate costs, interest expense, and income tax rate. This is consistent with the methodology and financial metrics that we provided at our 2025 Investor Day. I'll now turn the call over to Lori, who will begin on slide three.

Lori KochCEO

Good morning, and thanks, everyone, for joining our call. Earlier today, we reported our third quarter financial results, which again exceeded our previously communicated guidance, demonstrating the strength of our portfolio and the consistent execution of our team. Broad-based sales growth combined with a continued focus on productivity enabled organic growth of 5%, 90 basis points of margin expansion, 31% adjusted EPS growth, and robust free cash flow conversion in the quarter. As a result of our performance, we are again raising our full year 2026 financial guidance for organic sales growth, operating EBITDA, and adjusted EPS, all at or above the high end of our previously communicated range. Antonella will provide further details shortly. We also continue to execute our capital allocation priorities. We completed the previously announced $250 million ASR and substantially completed an additional $100 million of open market purchases in the quarter.

Lori KochCEO

We also announced our intention to repurchase another $250 million of shares in the fourth quarter. This underscores our confidence in DuPont's long-term growth potential and reinforces our focus on allocating capital where we see compelling return opportunities, including investing in our own shares. Overall, this was another solid quarter of strong execution. We delivered strong organic growth, expanded margins, generated robust free cash flow, and returned meaningful capital to shareholders, all while continuing to advance our strategic priorities. Moving to our strategic priorities on slide 4. We continue to strengthen the operating framework that connects our culture, planning, and execution. Our focus remains on accountability, productivity, and performance excellence, with the objective of building a more consistent and sustainable growth engine. Innovation excellence continues to strengthen DuPont's ability to turn differentiated technologies and application expertise into opportunities for sustainable growth.

Lori KochCEO

We are enhancing the quality of our innovation portfolio through more rigorous portfolio management, stronger visibility to accretive growth opportunities, and differential resource allocation. In the past quarter, we substantially increased our front-end innovation pipeline and increased the grow versus renew ratio of our innovation portfolio by about 5%, ensuring that our vitality index remains strong in the mid-30% range. The results are increasingly visible across our growth markets. In Water Technologies, we expanded our bioprocessing portfolio with a new purification technology aimed at the fast-growing peptide therapeutics market, including GLP-1 drugs. This product helps pharmaceutical manufacturers achieve the purity, yield, and scale needed to meet rising demand for these therapies. In addition, we launched Tyvek with renewable attribution in the quarter, which provides customers with a solution that maintains the superior performance they know while supporting progress on sustainable material sourcing and carbon footprint reduction.

Lori KochCEO

Commercially, we continue to see strong order patterns, with the total company order book solidly up double digits year-over-year. In addition, we are strengthening the connection across innovation, marketing, and sales into a more systemic growth engine, enabling better win rates, faster activation of sales plays, stronger launch readiness, and more disciplined execution from opportunity creation through conversion. The focus on this connection is driving key customer wins. Our adhesive business recently secured a customer win with BETATECH, an advanced thermal material that maintains optimal battery temperatures and helps automakers enhance vehicle performance, reliability, and circularity. Our Vespel custom-engineered seals were recently selected for their exceptional durability, wear resistance, and thermal stability, enabling safe, reliable fuel transfer during launch operations and showcasing our ability to solve complex aerospace challenges.

Lori KochCEO

In addition, we were recently awarded the largest containerized desalination project in EMEA, where our ultrafiltration modules provide greater efficiencies from a cost and space perspective, increasing the amount of clean drinking water that can be produced in each container. Operational excellence continues to deliver measurable results. We completed more than 20 Kaizen events during the quarter across our businesses and functions, with a continued focus on safety, quality, delivery, inventory, and cost. We are seeing the results of this work in our key performance indicators, delivering over 2% net productivity in the quarter, which was also a key component of our margin expansion. Additionally, our OTIF improved by more than 100 basis points, marking the third consecutive quarter of improvement. More broadly, the adoption of AI tools continues to accelerate as we work to connect our business system framework to AI-enabled toolsets.

Lori KochCEO

We are seeing faster and better decision-making from our teams on the factory floor, where we are starting to realize material benefits in the areas of planning and quality. Our 2026 financial performance continues to demonstrate the strength and quality of our portfolio, positioning us above the high end of all of the medium-term targets we established at Investor Day. We have a strong foundation for consistent profitable growth, supported by attractive end market exposure, continued operating leverage, and robust cash generation. We will enter 2027 with confidence in our ability to execute and the significant opportunity we have to drive earnings growth and create long-term shareholder value. With that, I will now turn the call over to Antonella to cover the financials and outlook in more detail.

Antonella FranzenCFO

Thanks, Lori, and good morning, everyone. Strong operational execution and broad-based growth drove another quarter of results ahead of our financial guidance. Organic growth and disciplined productivity translated into strong operating leverage and meaningful margin expansion. Additionally, our businesses continue to convert earnings into cash at a high rate, giving us significant financial flexibility. Beginning with our third quarter financial highlights on slide 5. Net sales of $1.9 billion were up 4% versus the year-ago period on 5% organic sales growth, partially offset by a 1% headwind from currency. Top-line growth was broad-based, led by continued strength in healthcare and aerospace, as well as year-over-year growth in Building Technologies on gains in North America and Asia. From a segment view, during the quarter, organic sales grew 4% in Healthcare & Water Technologies and 5% in Diversified Industrials.

Antonella FranzenCFO

Third quarter operating EBITDA of $469 million increased 8% versus the year-ago period on organic sales growth and productivity. This resulted in operating EBITDA margin of 25.1% in the quarter, an increase of 90 basis points year over year. Turning to cash flow, we delivered transaction-adjusted free cash flow of $341 million and related conversion of 121%, underpinned by earnings growth and net working capital productivity. Based on our year-to-date results, we now expect our full-year free cash flow conversion to be approximately 100%, nicely ahead of our 90% target. Turning to slide 6. Adjusted EPS for the quarter of $2.09 was up 31% versus the year-ago period. Stronger operations, benefits from higher cash, capital allocation, and actions taken to lower the tax rate drove 24% of the increase. Turning to our segment results on slide 7.

Antonella FranzenCFO

Healthcare & Water Technologies's third quarter net sales of $865 million were up 4% versus the year-ago period on 4% organic growth. For the third quarter, healthcare sales were up mid-single digits percent on an organic basis versus the year-ago period. Organic growth was led by double-digit gains in personal protection and medical packaging. Water sales were up low single digits percent on an organic basis on strength in industrial water and double-digit gains in semiconductor and specialty markets, partially offset by continued disruptions in the Middle East. Excluding the Middle East, organic sales increased mid-single digits percent in the quarter. Operating EBITDA for the segment during the quarter of $263 million was up 7% versus the year-ago period on organic growth and productivity gains. Strong operating leverage resulted in operating EBITDA margin of 30.4%, an increase of 80 basis points year over year. Turning to Diversified Industrials. Third quarter net sales of $1 billion increased 4% versus the year ago period on 5% organic sales growth, partially offset by a 1% headwind from currency.

Antonella FranzenCFO

At the line of business level, organic sales for Building Technologies were up mid-single digits percent on growth in North America and Asia. Growth in North America was broad-based, led by share gains and building envelopes for residential markets. Industrial Technologies organic sales were up mid-single digits percent on double-digit gains in aerospace and EV battery applications. Operating EBITDA for Diversified Industrials of $242 million was up 11% versus the year ago period on organic growth and productivity. This translated to operating EBITDA margin in the quarter of 24.1%, an increase of 140 basis points versus the year ago period. Turning to slide 8. We are again raising our full year 2026 financial guidance with all metrics at or above the high end of our previously communicated range.

Antonella FranzenCFO

For the full year 2026, our net sales guidance now assumes organic growth to be approximately 4.5%, reflecting our performance to date and continued strength across most of our key end markets. We now expect sales to be about $7.19 billion, an increase of $15 million from the midpoint of our prior guidance and at the top end of our prior guidance range. While we have the orders in hand for our large water projects in the Middle East, given the continued disruptions, our guidance now assumes these projects will be pushed into 2027. Continued strength in our other end markets allowed us to raise our guidance to the high end of our previous range.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day